AAD Cochrane Scholarship
This award program is founded on the goal of expanding the training in — and reach of — evidence-based medicine in dermatology.
Award: Two annual AAD Cochrane Scholars will be chosen to receive a travel grant to attend the 2024 Cochrane Colloquium and develop a systematic review on a topic that supports AAD Clinical Guideline development. The Clinical Guidelines Committee will provide the topics for the systematic review based on current priorities. This year, scholars will be able to choose whether to conduct their systematic review on a topic related to melanoma or hidradenitis suppurativa. These efforts will support AAD clinical guideline development or update and highlight areas for future dermatologic research.
Each scholar will serve as a second reviewer for their co-awardee’s literature search. The scholar will ultimately prepare and submit a publication-quality systematic review for consideration of publication in the JAAD. The review should be completed within 12-18 months following the 2024 colloquium. Prior recipients have contributed significantly to the AAD Clinical Guidelines Committee and have had the opportunity to pursue leadership opportunities.
Successful applicants often have had experience conducting systematic reviews. However, anyone with an interest in learning how to complete one is invited to apply.
Awardees will also be introduced to the Cochrane Skin Group to network internationally with other individuals committed to developing systematic reviews related to dermatology.
Date and location: Details for the 2024 Cochrane Colloquium location have not been announced but the colloquia have traditionally been held in the fall throughout the world. For additional information about the 2023 Cochrane Colloquium, please visit their event page. You can also access information about past colloquia.
Applications are being accepted July 3 to Sept. 15, 2023 for travel to the 2024 Colloquium.
For questions or more information, please contact Sameer Malik at firstname.lastname@example.org.
Apply for the scholarship
Receive a travel grant to attend the 2024 Cochrane Colloquium.Apply now
US/Canadian AAD members and residents
Only one lifetime receipt of award
Fill out the online submission form.
The form requires applicants to answer the following questions:
What prior experience or training do you have with systematic reviews?
What prior experience or training do you have with statistics and evidence-based medicine?
Have you previously attended a Cochrane meeting? If so which ones?
Why are you interested in attending this Cochrane meeting?
What subject areas or topics are you interested in reviewing if you receive this award?
Include the following material with the form submission:
Letter of recommendation/support (if resident/fellow application this should be from the Program Director).
Detailed CV including a listing of your peer-reviewed publications (if applicable).
Current AAD Conflict of Interest Disclosure on record.
Alex Ortega-Loayza, MD
Brandon Adler, MD
Audrey Jacobsen, MD, MPH
Annie Langley, MD, MSc
Peter Shumaker, MD
Kachiu Lee, MD
Jerry Brewer, MD
Cathryn Sibbald, MD
Hadar Lev-Tov, MD, MAS
William W. Huang, MD, MPH
Esther Freeman, MD, PhD
Peggy Wu, MD, MPH
This scholarship builds capacity for AAD member understanding of and participation in evidence reviews. It fosters methodological expertise and encourages member participation in AAD guideline development efforts - ultimately improving the guideline development process and contributing to dermatology research.
Esther Freeman, MD
Clinical Guidelines Committee, Immediate past Chair
Atopic Dermatology Guideline Workgroup, GRADE expert.
Peggy Wu, MD
Clinical Guidelines Committee, Chair 2021
Ebba Wennberg, Phillip Q. Richards, Paul A. Bain, Victor Huang, Sydney D. Sullivan, Emanual M. Maverakis, Gabriel E. Molina, Peggy A. Wu. Topical treatments for early-stage mycosis fungoides using Grading Recommendations Assessment, Development and Evaluation (GRADE) criteria: A systematic review, JAAD International, Volume 3, 2021, Pages 26-41, ISSN 2666-3287, doi.org/10.1016/j.jdin.2021.01.002.
Valipour A, Jäger M, Wu P, Schmitt J, Bunch C, Weberschock T. Interventions for mycosis fungoides. Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD008946. doi: 10.1002/14651858.CD008946.pub3
Jerry Brewer, MD
Appropriate Use Criteria [AUC] rating panel for two years
MoHS AUC medical writer 2021
"Local Recurrence of Melanoma Is Higher After Wide Local Excision Versus Mohs Micrographic Surgery or Staged Excision: A Systematic Review and Meta-analysis" provisionally accepted for publication by Dermatologic Surgery.
Kachiu C. Lee, MD and Peter Shumaker, MD
Buhalog B, Moustafa F, Arkin L, Lee K, Siwy K, Donelan M, Hultman CS, Shumaker PR. Ablative fractional laser treatment of hypertrophic burn and traumatic scars: a systematic review of the literature. Arch Dermatol Res. 2021 Jul;313(5):301-317. doi: 10.1007/s00403-020-02135-5. Epub 2020 Sep 14.
Okhovat J, Shumaker P, Lee K. Comparison of the safety and efficacy of daylight photodynamic therapy and conventional photodynamic therapy for actinic keratoses: A systematic review demonstrating noninferiority. Journal of the American Academy of Dermatology In Press Corrected Proof Published online: June 28, 2021.
Audrey Jacobsen, MD, MPH and Annie Langley, MD, MSc
Jacobsen A, Olabi B, Langley A, Beecker J, Mutter E, Shelley A, Worley B, Ramsay T, Saavedra A, Parker R, Stewart F, Pardo Pardo J. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome. Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.